In contrast, CLL cell resistance to CDC predominates in IGHV unmutated patients and was related to an important α2-6 sialyl transferase activity, which in turn increases cell surface α2-6 hypersialylation. Here, IGKV6-21 is linked to B-cell chronic lymphocytic leukemia.